Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bococizumab cardiovascular outcomes trial in high-risk subjects
2013-002795-41Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atherosclerosis and cardiac morbidity comparing Bococizumab plus background lipid-lowering therapy with Placebo plus background lipid-lowering therapy (2 arms). Started Nov 2013; status: completed.
02
Drugs
bococizumab
03
Conditions
atherosclerosiscardiac morbidity
Beyond the preview
Go deeper on 2013-002795-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002795-41.